CD36 and hepatocellular carcinoma: Animal experiments have revealed that CD36 is upregulated in metastasis-associated macrophages (MAM) within the HCC microenvironment, promoting the development of hepatic metastasis and fostering a heightened infiltration of M2-like MAM, thereby creating a highly immunosuppressed TME.